Comparing outcomes in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration treated with two different doses of primary intravitreal bevacizumab: results of the pan-american collaborative retina study group (PACORES) at the 12-month follow-up

Simple item page
dc.contributor.authorLihteh Wu
dc.contributor.authorJ. Fernando Arévalo
dc.contributor.authorMaurício Maia
dc.contributor.authorMaría H. Berrocal
dc.contributor.authorJ. García Sánchez
dc.contributor.authorTeodoro Evans
dc.contributor.authorTeodoro Evans
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T15:01:36Z
dc.date.available2026-03-22T15:01:36Z
dc.date.issued2009
dc.descriptionCitaciones: 11
dc.identifier.doi10.1007/s10384-008-0622-y
dc.identifier.urihttps://doi.org/10.1007/s10384-008-0622-y
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/49946
dc.language.isoen
dc.publisherSpringer Science+Business Media
dc.relation.ispartofJapanese Journal of Ophthalmology
dc.sourceUniversidad Hispanoamerica
dc.subjectMacular degeneration
dc.subjectChoroidal neovascularization
dc.subjectMedicine
dc.subjectBevacizumab
dc.subjectOphthalmology
dc.subjectRetina
dc.subjectNeovascularization
dc.titleComparing outcomes in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration treated with two different doses of primary intravitreal bevacizumab: results of the pan-american collaborative retina study group (PACORES) at the 12-month follow-up
dc.typearticle

Files

Collections

Artículo Científico Publicado